High content, multi-parameter analyses in buccal cells to identify alzheimer’s disease

Current Alzheimer Research

Volumn 13, Issue 7, 2016, Pages 787-799

  François, Maxime ^a,b,i   Fenech, Michael F ^a,i   Thomas, Philip ^a,i   Hor, Maryam ^a,i   Rembach, Alan ^c,i   Martins, Ralph N ^b,d   Rainey Smith, Stephanie R ^b,d,i   Masters, Colin L ^c   Ames, David ^e   Rowe, Christopher C ^f   Lance Macaulay, S ^a   Hill, Andrew F ^c,g,h,i   Leifert, Wayne R ^a,i   Appannah, Arti ⁱ   Barnes, Mary ⁱ   Barnham, Kevin ⁱ   Bedo, Justin ⁱ   Bellingham, Shayne ⁱ   Bon, Lynette ⁱ   Bourgeat, Pierrick ⁱ   Brown, Belinda ⁱ   Buckley, Rachel ⁱ   Burnham, Samantha ⁱ   Bush, Ashley ⁱ   Chandler, Graeme ⁱ   Chen, Karren ⁱ   Clarnette, Roger ⁱ   Collins, Steven ⁱ   Cooke, Ian ⁱ   Cowie, Tiffany ⁱ   Cox, Kay ⁱ   Cuningham, Emily ⁱ   Cyarto, Elizabeth ⁱ   Dang, Phuong Anh Vu ⁱ   Darby, David ⁱ   Desmond, Patricia ⁱ   Doecke, James ⁱ   Dore, Vincent ⁱ   Downing, Harriet ⁱ   Dridan, Belinda ⁱ   Duesing, Konsta ⁱ   Fahey, Michael ⁱ   Farrow, Maree ⁱ   Faux, Noel ⁱ   Fernandez, Shane ⁱ   Fernando, Binosha ⁱ   Fowler, Chris ⁱ   Fripp, Jurgen ⁱ   Frost, Shaun ⁱ   Gardener, Samantha ⁱ   Gibson, Simon ⁱ   Graham, Petra ⁱ   Gupta, Veer ⁱ   Hansen, David ⁱ   Harrington, Karra ⁱ   Hone, Eugene ⁱ   Horne, Malcolm ⁱ   Huckstepp, Brenda ⁱ   Jones, Andrew ⁱ   Jones, Gareth ⁱ   Kamer, Adrian ⁱ   Kanagasingam, Yogi ⁱ   Keam, Lisa ⁱ   Kowalczyk, Adam ⁱ   Krivdic, Betty ⁱ   Lam, Chiou Peng ⁱ   Lamb, Fiona ⁱ   Lautenschlager, Nicola ⁱ   Laws, Simon ⁱ   Lenzo, Nat ⁱ   Leroux, Hugo ⁱ   Lftikhar, Falak ⁱ   Li, Qiao Xin ⁱ   Lim, Florence ⁱ   Lim, Lucy ⁱ   Lockett, Linda ⁱ   Lucas, Kathy ⁱ   Mano, Mark ⁱ   Marczak, Caroline ⁱ   Martins, Georgia ⁱ   Maruff, Paul ⁱ   Matsumoto, Yumiko ⁱ   Bird, Sabine ⁱ   McBride, Simon ⁱ   McKay, Rachel ⁱ   Mulligan, Rachel ⁱ   Nash, Tabitha ⁱ   Nigro, Julie ⁱ   O'Keefe, Graeme ⁱ   Ong, Kevin ⁱ   Parker, Bernadette ⁱ   Pedrini, Steve ⁱ   Peiffer, Jeremiah ⁱ   Pejoska, Sveltana ⁱ   Penny, Lisa ⁱ   Perez, Keyla ⁱ   Pertile, Kelly ⁱ   Phal, Pramit ⁱ   Porter, Tenielle ⁱ   Raniga, Parnesh ⁱ   Restrepo, Carolina ⁱ   Riley, Malcolm ⁱ   Roberts, Blaine ⁱ   Robertson, Jo ⁱ   Rodrigues, Mark ⁱ   Rooney, Alicia ⁱ   Rumble, Rebecca ⁱ   Ryan, Tim ⁱ   Salvado, Olivier ⁱ   Samuel, Mather ⁱ   Saunders, Ian ⁱ   Savage, Greg ⁱ   Silbert, Brendan ⁱ   Sohrabi, Hamid ⁱ   Syrette, Julie ⁱ   Szoeke, Cassandra ⁱ   Taddei, Kevin ⁱ   Taddei, Tania ⁱ   Tan, Sherilyn ⁱ   Tegg, Michelle ⁱ   Trivedi, Darshan ⁱ   Trounson, Brett ⁱ   Veljanovski, Robyn ⁱ   Verdile, Giuseppe ⁱ   Villemagne, Victor ⁱ   Volitakis, Irene ⁱ   Vockler, Cassandra ⁱ   Vovos, Michael ⁱ   Vrantsidis, Freda ⁱ   Walker, Stacey ⁱ   Watt, Andrew ⁱ   Weinborn, Mike ⁱ   Wilson, Bill ⁱ   Woodward, Michael ⁱ   Yastrubetskaya, Olga ⁱ   Yates, Paul ⁱ   Zhang, Ping ⁱ   Chatterjee, Pratishtha ⁱ   Creegan, Rhona ⁱ   De Ruyck, Karl ⁱ   Ding, Hang ⁱ   Groth, David ⁱ   Head, Richard ⁱ   Krause, Debra ⁱ   Lachovitzki, Rebecca ⁱ   Lim, Yen Ying ⁱ   Lintern, Teresa ⁱ   Mondal, Alinda ⁱ   Nuttall, Stewart ⁱ   O'Callaghan, Nathan ⁱ   Osborne, Lisa ⁱ   Pang, Chaoyi ⁱ   Patten, Glen ⁱ   Tuckfield, Alison ⁱ   Varghese, Jose ⁱ   Wilson, Andrea ⁱ   Zhang, Qing ⁱ   more..

^a CSIRO   (Australia)

^b EDITH COWAN UNIVERSITY   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d HOLLYWOOD PRIVATE HOSPITAL   (Australia)

^e NATIONAL AGEING RESEARCH INSTITUTE   (Australia)

^f AUSTIN HEALTH   (Australia)

^g UNIVERSITY OF MELBOURNE   (Australia)

^h LA TROBE UNIVERSITY   (Australia)

ⁱ NONE

Author keywords

Alzheimer's disease; Amyloid; Buccal cells; DNA content; Laser scanning cytometry; Mild cognitive impairment; Neutral lipids

Indexed keywords

AMYLOID BETA PROTEIN; BIOLOGICAL MARKER; CELL NUCLEUS DNA; TAU PROTEIN; AMYLOID BETA-PROTEIN (1-42); AZO COMPOUND; DNA; OIL RED O; PEPTIDE FRAGMENT; PLASMA PROTEIN;

AGED; ALZHEIMER DISEASE; ANEUPLOIDY; ARTICLE; CELL DIFFERENTIATION; CHEEK CELL; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOLOGY; DNA CONTENT; FEMALE; HUMAN; LASER SCANNING CYTOMETRY; MALE; MILD COGNITIVE IMPAIRMENT; MINI MENTAL STATE EXAMINATION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; ANALYSIS OF VARIANCE; COGNITIVE DEFECT; COHORT ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; MENTAL HEALTH; METABOLISM; MOUTH MUCOSA; PATHOLOGY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANALYSIS OF VARIANCE; AZO COMPOUNDS; BLOOD PROTEINS; COGNITIVE DYSFUNCTION; COHORT STUDIES; DNA; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; LASER SCANNING CYTOMETRY; MALE; MENTAL STATUS SCHEDULE; MOUTH MUCOSA; PEPTIDE FRAGMENTS; TAU PROTEINS;

EID: 84974693329     PISSN: 15672050     EISSN: 18755828     Source Type: Journal    
DOI: 10.2174/1567205013666160315112151     Document Type: Article

References (54)

1. Burns A, Byrne EJ, Maurer K. Alzheimer's disease. Lancet 360(9327): 163-165 (2002).
2. Alzheimer's Association, Thies W, Bleiler L. 2011 Alzheimer's disease facts and figures. Alzheimers Dement 7(2): 208-244 (2011).
3. Prince M, Bryce R, Albanese E, Wimo A, Ribeiro W, Ferri CP. The global prevalence of dementia: a systematic review and metaanalysis. Alzheimers Dement 9(1): 63-75.e2 (2013).
4. Sloane PD, Zimmerman S, Suchindran C, Reed P, Wang L, Boustani M, et al. The public health impact of Alzheimer's disease, 2000-2050: potential implication of treatment advances. Annu Rev Public Health 23: 213-231 (2002).
5. Smith AD. The worldwide challenge of the dementias: a role for B vitamins and homocysteine? Food Nutr Bull 29(2): S143-172 (2008).
6. Ferri CP, Prince M, Brayne C, Brodaty H, Fratiglioni L, Ganguli M, et al. Global prevalence of dementia: a Delphi consensus study. Lancet 366(9503): 2112-2117 (2005).
7. Selkoe DJ. Alzheimer's disease results from the cerebral accumulation and cytotoxicity of amyloid beta-protein. J Alzheimers Dis 3(1): 75-80 (2001).
8. Grundke-Iqbal I, Iqbal K, Tung YC, Quinlan M, Wisniewski HM, Binder LI. Abnormal phosphorylation of the microtubuleassociated protein tau (tau) in Alzheimer cytoskeletal pathology. Proc Natl Acad Sci USA 83(13): 4913-4917 (1986).
9. Blennow K, Zetterberg H. Cerebrospinal fluid biomarkers for Alzheimer's disease. J Alzheimers Dis 18(2): 413-417 (2009).
10. Prvulovic D, Hampel H. Amyloid beta (Abeta) and phospho-tau (ptau) as diagnostic biomarkers in Alzheimer's disease. Clin Chem Lab Med 49(3): 367-374 (2011).
11. Mapstone M, Cheema AK, Fiandaca MS, Zhong X, Mhyre TR, Macarthur LH, et al. Plasma phospholipids identify antecedent memory impairment in older adults. Nat Med 20(4): 415-418 (2014).
12. Rembach A, Faux NG, Watt AD, Pertile KK, Rumble RL, Trounson BO, et al. Changes in plasma amyloid beta in a longitudinal study of aging and Alzheimer's disease. Alzheimers Dement 10(1): 53-61 (2014).
13. Doecke JD, Laws SM, Faux NG, Wilson W, Burnham SC, Lam CP, et al. Blood-based protein biomarkers for diagnosis of Alzheimer disease. Arch Neurol 69(10): 1318-1325 (2012).
14. Francois M, Leifert W, Martins R, Thomas P, Fenech M. Biomarkers of Alzheimer's Disease Risk in Peripheral Tissues; Focus on Buccal Cells. Curr Alzheimer Res 11: 519-531 (2014).
15. Mathur S, Glogowska A, McAvoy E, Righolt C, Rutherford J, Willing C, et al. Three-dimensional quantitative imaging of te lomeres in buccal cells identifies mild, moderate, and severe Alzheimer's disease patients. J Alzheimers Dis 39(1): 35-48 (2014).
16. Migliore L, Coppede F, Fenech M, Thomas P. Association of micronucleus frequency with neurodegenerative diseases. Mutagenesis 26(1): 85-92 (2011).
17. Thomas P, O'Callaghan NJ, Fenech M. Telomere length in white blood cells, buccal cells and brain tissue and its variation with ageing and Alzheimer's disease. Mech Ageing Dev 129(4): 183-190 (2008).
18. Thomas P, Hecker J, Faunt J, Fenech M. Buccal micronucleus cytome biomarkers may be associated with Alzheimer's disease. Mutagenesis 22(6): 371-379 (2007).
19. Thomas P, Holland N, Bolognesi C, Kirsch-Volders M, Bonassi S, Zeiger E, et al. Buccal micronucleus cytome assay. Nat Protoc 4(6): 825-837 (2009).
20. Fischer HG, Morawski M, Bruckner MK, Mittag A, Tarnok A, Arendt T. Changes in neuronal DNA content variation in the human brain during aging. Aging Cell 11(4): 628-633 (2012).
21. Mosch B, Morawski M, Mittag A, Lenz D, Tarnok A, Arendt T. Aneuploidy and DNA replication in the normal human brain and Alzheimer's disease. J Neurosci 27(26): 6859-6867 (2007).
22. Francois M, Leifert W, Hecker J, Faunt J, Martins R, Thomas P, et al. Altered cytological parameters in buccal cells from individuals with mild cognitive impairment and Alzheimer's disease. Cytometry A 85A(8): 698-708 (2014).
23. Han X. Lipid alterations in the earliest clinically recognizable stage of Alzheimer's disease: implication of the role of lipids in the pathogenesis of Alzheimer's disease. Curr Alzheimer Res 2(1): 65-77 (2005).
24. Han X, Holtzman DM, McKeel DW, Jr. Plasmalogen deficiency in early Alzheimer's disease subjects and in animal models: molecular characterization using electrospray ionization mass spectrometry. J Neurochem 77(4): 1168-1180 (2001).
25. Puglielli L, Tanzi RE, Kovacs DM. Alzheimer's disease: the cholesterol connection. Nat Neurosci 6(4): 345-351 (2003).
26. Pani A, Dessi S, Diaz G, La Colla P, Abete C, Mulas C, et al. Altered cholesterol ester cycle in skin fibroblasts from patients with Alzheimer's disease. J Alzheimers Dis 18(4): 829-841 (2009).
27. Pani A, Mandas A, Diaz G, Abete C, Cocco PL, Angius F, et al. Accumulation of neutral lipids in peripheral blood mononuclear cells as a distinctive trait of Alzheimer patients and asymptomatic subjects at risk of disease. BMC Med 7: 66 (2009).
28. Luther E, Kamentsky L, Henriksen M, Holden E. Next-generation laser scanning cytometry. Methods Cell Biol 75: 185-218 (2004).
29. Pozarowski P, Holden E, Darzynkiewicz Z. Laser scanning cytometry: principles and applications. Methods Mol Biol 319: 165-192 (2006).
30. Ellis KA, Bush AI, Darby D, De Fazio D, Foster J, Hudson P, et al. The Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging: methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of Alzheimer's disease. Int Psychogeriatr 21(4): 672-687 (2009).
31. Faux NG, Ellis KA, Porter L, Fowler CJ, Laws SM, Martins RN, et al. Homocysteine, vitamin B12, and folic acid levels in Alzheimer's disease, mild cognitive impairment, and healthy elderly: baseline characteristics in subjects of the Australian Imaging Biomarker Lifestyle study. J Alzheimers Dis 27(4): 909-922 (2011).
32. Nunan J, Shearman MS, Checler F, Cappai R, Evin G, Beyreuther K, et al. The C-terminal fragment of the Alzheimer's disease amyloid protein precursor is degraded by a proteasome-dependent mechanism distinct from gamma-secretase. Eur J Biochem 268(20): 5329-5336 (2001).
33. Ryan TM, Caine J, Mertens HD, Kirby N, Nigro J, Breheney K, et al. Ammonium hydroxide treatment of Abeta produces an aggregate free solution suitable for biophysical and cell culture characterization. Peer J 1: e73 (2013).
34. M. Francois. Discovery of new biomarkers of mild cognitive impairment and Alzheimer's disease risk in buccal cells using laser scanning cytometry. Adelaide: Edith Cowan University; (2013).
35. de Oliveira RM, Lia EN, Guimaraes RM, Bocca AL, Cavalcante Neto FF, da Silva TA. Cytologic and cytometric analysis of oral mucosa in Alzheimer's disease. Anal Quant Cytol Histol 30(2): 113-118 (2008).
36. Thomas P, Fenech M. Chromosome 17 and 21 aneuploidy in buccal cells is increased with ageing and in Alzheimer's disease. Mutagenesis 23(1): 57-65 (2008).
37. Leifert WR, Francois M, Thomas P, Luther E, Holden E, Fenech M. Automation of the buccal micronucleus cytome assay using laser scanning cytometry. Methods Cell Biol 102: 321-339 (2011).
38. Darzynkiewicz Z, Traganos F, Sharpless TK, Melamed MR. Cell cycle-related changes in nuclear chromatin of stimulated lymphocytes as measured by flow cytometry. Cancer Res 37(12): 4635-4640 (1977).
39. Shapiro IM, Moar MH, Ohno S, Klein G. Acetic acid treatment denatures DNA while preserving chromosomal morphology during the in situ hybridization procedure. Exp Cell Res 115(2): 411-414 (1978).
40. Darzynkiewicz Z, Traganos F, Kapuscinski J, Staiano-Coico L, Melamed MR. Accessibility of DNA in situ to various fluorochromes: relationship to chromatin changes during erythroid differentiation of Friend leukemia cells. Cytometry 5(4): 355-363 (1984).
41. Evenson D, Darzynkiewicz Z, Jost L, Janca F, Ballachey B. Changes in accessibility of DNA to various fluorochromes during spermatogenesis. Cytometry 7(1): 45-53 (1986).
42. Soderberg M, Edlund C, Alafuzoff I, Kristensson K, Dallner G. Lipid composition in different regions of the brain in Alzheimer's disease/senile dementia of Alzheimer's type. J Neurochem 59(5): 1646-1653 (1992).
43. Soderberg M, Edlund C, Kristensson K, Dallner G. Lipid compositions of different regions of the human brain during aging. J Neurochem 54(2): 415-423 (1990).
44. Spires-Jones TL, Stoothoff WH, de Calignon A, Jones PB, Hyman BT. Tau pathophysiology in neurodegeneration: a tangled issue. Trends Neurosci 32(3): 150-159 (2009).
45. Hattori H, Matsumoto M, Iwai K, Tsuchiya H, Miyauchi E, Takasaki M, et al. The tau protein of oral epithelium increases in Alzheimer's disease. J Gerontol A Biol Sci Med Sci 57(1): M64-70 (2002).
46. Neumann K, Farias G, Slachevsky A, Perez P, Maccioni RB. Human platelets tau: a potential peripheral marker for Alzheimer's disease. J Alzheimers Dis 25(1): 103-109 (2011).
47. Armentero MT, Sinforiani E, Ghezzi C, Bazzini E, Levandis G, Ambrosi G, et al. Peripheral expression of key regulatory kinases in Alzheimer's disease and Parkinson's disease. Neurobiol Aging 32(12): 2142-2151 (2011).
48. Arnold SE, Lee EB, Moberg PJ, Stutzbach L, Kazi H, Han LY, et al. Olfactory epithelium amyloid-beta and paired helical filamenttau pathology in Alzheimer disease. Ann Neurol 67(4): 462-469 (2010).
49. Schupf N, Tang MX, Fukuyama H, Manly J, Andrews H, Mehta P, et al. Peripheral Abeta subspecies as risk biomarkers of Alzheimer's disease. Proc Natl Acad Sci USA 105(37): 14052-14057 (2008).
50. Ko SY, Chang KW, Lin SC, Hsu HC, Liu TY. The repressive effect of green tea ingredients on amyloid precursor protein (APP) expression in oral carcinoma cells in vitro and in vivo. Cancer Lett 245(1-2): 81-89 (2007).
51. Khan AA, Mao XO, Banwait S, Jin K, Greenberg DA. Neuroglobin attenuates beta-amyloid neurotoxicity in vitro and transgenic Alzheimer phenotype in vivo. Proc Natl Acad Sci USA 104(48): 19114-19119 (2007).
52. Selkoe DJ. Amyloid protein and Alzheimer's disease. Sci Am 265(5): 68-71, 74-6, 78 (1991).
53. De-Paula VJ, Radanovic M, Diniz BS, Forlenza OV. Alzheimer's disease. Subcell Biochem 65: 329-352 (2012).
54. Roher AE, Esh CL, Kokjohn TA, Castano EM, Van Vickle GD, Kalback WM, et al. Amyloid beta peptides in human plasma and tissues and their significance for Alzheimer's disease. Alzheimers Dement 5(1): 18-29 (2009).